Mabini, Loremae R.

HRN: 12-26-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2024
AMPICILLIN 1GM (VIAL)
05/20/2024
05/22/2024
IV
2g
Q8
PROM
Waiting Final Action 
05/21/2024
CEFUROXIME 500MG (TAB)
05/21/2024
05/27/2024
ORAL
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: